Breaking News: Massive Recall of Rohto Eye Drops Due to Contamination Fears

In a shocking move, the U.S. Food and Drug Administration (FDA) has issued a nationwide recall of nearly 12 million bottles of Rohto Cooling Eye Drops, citing concerns over potential microbial contamination. The recall, which affects eight different product varieties, was voluntarily initiated by the Vietnam-based manufacturer Rohto-Mentholatum. The affected products, including All-in-One, Max Strength, and Cool Relief, have been distributed by The Mentholatum Company and can be identified by their expiry dates, which range from July 2025 to February 2029. According to the FDA, the use of these eye drops can lead to non-life-threatening adverse health consequences, prompting the agency to classify the recall as a Class II recall. Consumers are advised to check their Rohto packaging against the FDA's recall list and to dispose of or return any affected products for a full refund. Those who have experienced any adverse reactions after using the drops are urged to consult a doctor immediately. This recall is the latest in a series of safety concerns surrounding eye products, following a similar recall by Lupin Pharmaceuticals earlier this year.